Daye

About:

Daye is a gynecological health company that creates products and services for vaginal treatment.

Website: https://yourdaye.com

Twitter/X: MeetDaye

Top Investors: Khosla Ventures, Index Ventures, Google for Startups, Salica, Kindred Capital

Description:

Daye is a gynecological health company that creates products and services for vaginal treatment. Its tampon-based at-home vaginal microbiome screening kit allows women to test themselves at their leisure. The kit is intended to screen for vaginal infections such as thrush and bacterial vaginosis (BV), as well as disruptions to the microbiome, which could put women at risk of STIs, gynecological cancers, and fertility and IVF complications. Daye will also launch a comprehensive digital platform for gynae health, with the goal of reducing pain, shame, and wasted time for women as they navigate their health journey from their first period to menopause. The company was founded in 2017

Total Funding Amount:

$17.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2017-01-01

Contact Email:

hello(AT)yourdaye.com

Founders:

Valentina Milanova

Number of Employees:

11-50

Last Funding Date:

2022-10-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai